Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The clinicomolecular landscape of de novo versus relapsed stage IV metastatic breast cancer

14 Feb 2020

Abstract excerpt

BACKGROUND: de novo metastatic breast cancer (dnMBC) is responsible for 6-10% of breast cancer presentations with increasing incidence and has remained resistant to detection by mammography screening. Recent publications hypothesized that in addition to poor screening uptake, the presentation of dnMBC may be due to its unfavourable biology which remains unknown at the molecular level. Here we investigated the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Breast Cancer Therapies
Share to Breast Cancer Treatment Studies
Share to Metastasis and carcinoma case studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32067942
DOI: 10.1016/j.yexmp.2020.104404

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The clinicomolecular landscape of de novo versus relapsed stage IV metastatic breast cancerPMID 32067942Read ↗

Genomic Characterization of De Novo Metastatic Breast Cancer.Semantic proximity Read ↗

The Influence of Cancer Molecular Subtypes and Treatment on the Mutation Spectrum in Metastatic Breast Cancers.Semantic proximity Read ↗

Genomic Characterization of de novo Metastatic Breast Cancer.Semantic proximity Read ↗

Survival and disease characteristics of de novo versus recurrent metastatic breast cancer in a cohort of young patients.Semantic proximity Read ↗

Differences in the Tumor Molecular and Microenvironmental Land-Scape Between Early (Non-metastatic) and De Novo Metastatic Primary Luminal Breast TumorsSemantic proximity Read ↗

Gene expression in metastatic breast cancer – patterns with prognostic potential in primary tumors and metastatic tissueSemantic proximity Read ↗

An Update on the Molecular Pathology of Metaplastic Breast CancerSemantic proximity Read ↗

The Present and Future of Clinical Management in Metastatic Breast CancerSemantic proximity Read ↗

Molecular features of untreated breast cancer and initial metastatic event inform clinical decision-making and predict outcome: long-term results of ESOPE, a single-arm prospective multicenter study.Semantic proximity Read ↗

Prelude to Malignancy: A Gene Expression Signature in Normal Mammary Gland from Breast Cancer Patients Suggests Pre-tumorous Alterations and Is Associated with Adverse OutcomesSemantic proximity Read ↗

Phenotypic and molecular dissection of metaplastic breast cancer and the prognostic implicationsSemantic proximity Read ↗

Genomic Features of Rapid Versus Late Relapse in Triple Negative Breast Cancer Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.